Nurse Practitioner, Psychiatric/Mental Health · Toms River, NJ
NPI
1821546094
Since 2016
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
448 Lakehurst Rd, Suite 2a
Toms River, NJ, 08755
Phone (732) 240-1300
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,655
165 services
Medicare patients, 2024
58
Average age 60
Drug cost, 2024
$375K
3,204 prescriptions
Company payments, 2025
$895
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Latisha L Marshall was code 99213 (office e&m - established), 93 times for 47 patients. In total Latisha L Marshall billed 165 services in 2 codes, and Medicare paid $6,655.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 93 | 47 | $34.85 | $3,241 |
| 99214 Office E&M - Established | Facility | 72 | 36 | $47.41 | $3,414 |
By year: 2022 $11K for 199 services; 2023 $6,129 for 115 services; 2024 $6,655 for 165 services.
Medicare prescription drug claims, 2024
In 2024, the drug Latisha L Marshall prescribed most often to Medicare patients was Clonazepam, with 239 prescriptions and refills. In total Latisha L Marshall wrote 3,204 Medicare prescriptions that cost $375K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clonazepam Generic | 239 | 241 | 27 | $1,900 |
| Quetiapine Fumarate Generic | 211 | 233 | 25 | $3,229 |
| Trazodone Hcl Generic | 206 | 230 | 27 | $2,098 |
| Sertraline Hcl Generic | 185 | 264 | 30 | $1,296 |
| Fluoxetine Hcl Generic | 171 | 227 | 21 | $1,422 |
| Escitalopram Oxalate Generic | 148 | 188 | 19 | $1,046 |
| Alprazolam Generic | 145 | 147 | 18 | $1,028 |
| Buspirone Hcl Generic | 138 | 167 | 20 | $2,358 |
| Olanzapine Generic | 109 | 145 | 13 | $3,285 |
| Lorazepam Generic | 108 | 116 | 13 | $542 |
| Oxcarbazepine Generic | 98 | 106 | 11 | $3,867 |
| Gabapentin Generic | 88 | 120 | Under 11 | $786 |
| Duloxetine Hcl Generic | 78 | 110 | Under 11 | $809 |
| Divalproex Sodium Er Divalproex Sodium | 78 | 86 | Under 11 | $3,286 |
| Risperidone Generic | 73 | 89 | Under 11 | $1,180 |
Brand drugs: 144 claims; generic drugs: 3,060 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Latisha L Marshall $895 ($895 in general payments such as food, travel and fees) from 9 companies. The largest payer was Neurocrine BioSciences, Inc. with $187.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 9 | $187 |
| Axsome Therapeutics, Inc. AXSM | 7 | $183 |
| Abbvie Inc. ABBV | 21 | $143 |
| Janssen Pharmaceuticals, Inc JNJ | 6 | $125 |
| Alkermes, Inc. ALKS | 5 | $86.54 |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $50.04 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $48.51 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $36.82 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $34.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.